|
Diabetes, Vol 46, Issue 9 1445-1452, Copyright © 1997 by American Diabetes Association
Insulin administration enhances growth of the beta-cell mass in streptozotocin-treated newborn rats
J Movassat, C Saulnier and B Portha
Laboratory of Physiopathology of Nutrition, Universite Paris, France.
We have previously reported that the damage caused by streptozotocin (STZ)
administration to the beta-cells in newborn rats was followed by
spontaneous recovery from neonatal diabetes. Our present data indicate that
STZ administration on the day of birth (day 1) reduced the total beta-cell
mass on day 4 to only 10% of the normal value and that after such damage,
27% of the corresponding normal beta-cell mass was spontaneously regained
on day 7. During days 4-7, the contribution of the predicted beta-cell
growth (due to the replication of preexisting differentiated beta-cells) to
the total beta-cell growth represented only 56%. Therefore, recruitment of
new beta-cells from a precursor pool indeed represents a significant
mechanism for beta-cell regeneration after STZ during this period of life.
Here, we report for the first time that 1) insulin therapy from days 2 to 4
did not significantly influence the occurrence of beta-cell damage after
STZ administration (total beta-cell mass on day 4 was reduced to 12% of the
normal value) and 2) insulin therapy from days 2 to 6 did improve the
otherwise spontaneous beta-cell regeneration, since on day 7 total
beta-cell mass was 44% of the corresponding normal beta-cell mass. During
days 4-7, the contribution of the predicted beta-cell growth to the total
beta-cell growth represented only 32% in the insulin-treated STZ group.
Finally the insulin-favored regeneration of the beta-cells reflects both an
increased replication from differentiated beta-cells and an increased
neogenesis from precursor/stem cells, with this last pathway being
preferentially activated.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Movassat and B. Portha
Early administration of keratinocyte growth factor improves {beta}-cell regeneration in rat with streptozotocin-induced diabetes
J. Endocrinol.,
November 1, 2007;
195(2):
333 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fernandez, M. A. Martin, S. Fajardo, D. Bailbe, M. N. Gangnerau, B. Portha, F. Escriva, P. Serradas, and C. Alvarez
Undernutrition does not alter the activation of beta-cell neogenesis and replication in adult rats after partial pancreatectomy
Am J Physiol Endocrinol Metab,
November 1, 2006;
291(5):
E913 - E921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Thyssen, E. Arany, and D. J. Hill
Ontogeny of Regeneration of {beta}-Cells in the Neonatal Rat after Treatment with Streptozotocin
Endocrinology,
May 1, 2006;
147(5):
2346 - 2356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li, Z. Yi, M. Seno, and I. Kojima
Activin A and Betacellulin: Effect on Regeneration of Pancreatic {beta}-Cells in Neonatal Streptozotocin-Treated Rats
Diabetes,
March 1, 2004;
53(3):
608 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paris, C. Bernard-Kargar, M.-F. Berthault, L. Bouwens, and A. Ktorza
Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic {beta}-Cell Mass in Vivo in Adult Rats
Endocrinology,
June 1, 2003;
144(6):
2717 - 2727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Friedrichsen, H. E. Richter, J. A. Hansen, C. J. Rhodes, J. H. Nielsen, N. Billestrup, and A. Moldrup
Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic {beta}-Cells
Mol. Endocrinol.,
May 1, 2003;
17(5):
945 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tourrel, D. Bailbe, M. Lacorne, M.-J. Meile, M. Kergoat, and B. Portha
Persistent Improvement of Type 2 Diabetes in the Goto-Kakizaki Rat Model by Expansion of the {beta}-Cell Mass During the Prediabetic Period With Glucagon-Like Peptide-1 or Exendin-4
Diabetes,
May 1, 2002;
51(5):
1443 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li, M. Seno, H. Yamada, and I. Kojima
Promotion of {beta}-Cell Regeneration by Betacellulin in Ninety Percent-Pancreatectomized Rats
Endocrinology,
December 1, 2001;
142(12):
5379 - 5385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tourrel, D. Bailbe, M.-J. Meile, M. Kergoat, and B. Portha
Glucagon-Like Peptide-1 and Exendin-4 Stimulate {beta}-Cell Neogenesis in Streptozotocin-Treated Newborn Rats Resulting in Persistently Improved Glucose Homeostasis at Adult Age
Diabetes,
July 1, 2001;
50(7):
1562 - 1570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. BERNARD, M.-F. BERTHAULT, C. SAULNIER, and A. KTORZA
Neogenesis vs. apoptosis as main components of pancreatic ß cell mass changes in glucose-infused normal and mildly diabetic adult rats
FASEB J,
July 1, 1999;
13(10):
1195 - 1205.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. T. Finegood, G. C. Weir, and S. Bonner-Weir
Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats
Am J Physiol Endocrinol Metab,
May 1, 1999;
276(5):
E822 - E827.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|